Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives-Reference-Cited by-同舟云学术

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

Published:2013-06 Issue:6 Volume:13 Page:697-709
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Santoni Matteo,De Tursi Michele,Felici Alessandra,Lo Re Giovanni,Ricotta Riccardo,Ruggeri Enzo Maria,Sabbatini Roberto,Santini Daniele,Vaccaro Vanja,Milella Michele

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/era.13.52

Reference88 articles.

1. Cancer statistics, 2012

2. Renal-Cell Carcinoma

3. Immunotherapy for Renal Cell Carcinoma

4. A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia

5. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma;Frontiers in Cell and Developmental Biology;2022-04-11

2. Causal Associations between Serum Urea and Cancer: A Mendelian Randomization Study;Genes;2021-03-29

3. Yeast extract inhibits the proliferation of renal cell carcinoma cells via regulation of iron metabolism;Molecular Medicine Reports;2019-08-20

4. Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma;Chinese Journal of Cancer;2017-05-18

5. Comparison of Tyrosine Kinase Inhibitor Versus Mammalian Target of Rapamycin Inhibitor as Second-line Molecular-targeted Therapy for Patients with Poor-risk Metastatic Renal Cell Carcinoma;ANTICANCER RES;2017